- Added to Email Alerts
Atopic Dermatitis
Latest News View All
-
EADV 2022Data Show Lebrikizumab Atopic Dermatitis Effects Maintained -
EADV 2022BREEZE-AD-PEDS: First Data for Baricitinib in Childhood Eczema
-
AlertFDA Approves Dupilumab for Treatment of Prurigo Nodularis
-
EADV 2022Study Identifies Skin Biomarkers That Predict Newborn Eczema Risk
-
Allergies Cluster and Have Predictable Trajectories
-
Early Emollient Use Reduces Dermatitis in At-Risk Infants
-
When Is an Allergic Reaction to Raw Plant Food Due to Tree Pollen?
-
EMA's CHMP Supports Use of Tralokinumab in Adolescents With AD
Perspective View All
Journal Articles View All
-
Airborne Anaphylaxis: Highlighting an Invisible Enemy
-
An Update on JAK Inhibitors in Skin Disease
-
Views and Beliefs of Vitiligo Patients in Online Forums
-
Cabozantinib Combined With Atezolizumab for Advanced RCC
-
JYNNEOS for PreP of Persons at Risk for Orthopoxviruses
-
Pruritus in Chronic Kidney Disease